Friedman SL, Neuschwander-Tetri BA, Rinella M, Sanyal AJ. Mechanisms of NAFLD development and therapeutic strategies. Nat Med. 2018;24:908–922. https://doi.org/10.1038/s41591-018-0104-9.
Article CAS PubMed PubMed Central Google Scholar
Younossi ZM, Golabi P, Paik JM, Henry A, Van Dongen C, Henry L. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology. 2023;77:1335–1347. https://doi.org/10.1097/hep.0000000000000004.
Zhou J, Zhou F, Wang W, Zhang XJ, Ji YX, Zhang P et al. Epidemiological Features of NAFLD From 1999 to 2018 in China. Hepatology. 2020;71:1851–1864. https://doi.org/10.1002/hep.31150.
Di Mauro S, Scamporrino A, Filippello A, Di Pino A, Scicali R, Malaguarnera R, et al. Clinical and Molecular Biomarkers for Diagnosis and Staging of NAFLD. Int J Mol Sci. 2021;22(21).https://doi.org/10.3390/ijms222111905.
Lombardi R, Pisano G, Fargion S. Role of Serum Uric Acid and Ferritin in the Development and Progression of NAFLD. Int J Mol Sci. 2016;17:548. https://doi.org/10.3390/ijms17040548.
Article CAS PubMed PubMed Central Google Scholar
Copur S, Demiray A, Kanbay M. Uric acid in metabolic syndrome: Does uric acid have a definitive role? Eur J Intern Med. 2022;103:4–12. https://doi.org/10.1016/j.ejim.2022.04.022.
Article CAS PubMed Google Scholar
Cui Y, Liu J, Shi H, Hu W, Song L, Zhao Q. Serum uric acid is positively associated with the prevalence of nonalcoholic fatty liver in non-obese type 2 diabetes patients in a Chinese population. J Diabetes Complications. 2021;35:107874. https://doi.org/10.1016/j.jdiacomp.2021.107874.
Article CAS PubMed Google Scholar
Liu J, Xu C, Ying L, Zang S, Zhuang Z, Lv H et al. Relationship of serum uric acid level with non-alcoholic fatty liver disease and its inflammation progression in non-obese adults. Hepatol Res. 2017;47:E104–E112. https://doi.org/10.1111/hepr.12734.
Article CAS PubMed Google Scholar
Bai JX, Shu RM, Huang Y, Peng Z. Correlation between serum uric acid and risk of new-onset nonalcoholic fatty liver disease: a 5-year observational cohort study. Zhonghua Gan Zang Bing Za Zhi. 2018;26:271–275. https://doi.org/10.3760/cma.j.issn.1007-3418.2018.04.008.
Article CAS PubMed Google Scholar
Li J, Zou B, Yeo YH, Feng Y, Xie X, Lee DH et al. Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999–2019: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2019;4:389–398. https://doi.org/10.1016/s2468-1253(19)30039-1.
Fan JG, Kim SU, Wong VW. New trends on obesity and NAFLD in Asia. J Hepatol. 2017;67:862–873. https://doi.org/10.1016/j.jhep.2017.06.003.
Wu S, Huang Z, Yang X, Zhou Y, Wang A, Chen L et al. Prevalence of ideal cardiovascular health and its relationship with the 4-year cardiovascular events in a northern Chinese industrial city. Circ Cardiovasc Qual Outcomes. 2012;5:487–493. https://doi.org/10.1161/circoutcomes.111.963694.
Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D et al. 2020 International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension. 2020;75:1334–1357. https://doi.org/10.1161/hypertensionaha.120.15026.
Article CAS PubMed Google Scholar
Jia W, Weng J, Zhu D, Ji L, Lu J, Zhou Z et al. Standards of medical care for type 2 diabetes in China 2019. Diabetes Metab Res Rev. 2019;35:e3158. https://doi.org/10.1002/dmrr.3158.
Gao X, Fan JG. Diagnosis and management of non-alcoholic fatty liver disease and related metabolic disorders: consensus statement from the Study Group of Liver and Metabolism. Chinese Society of Endocrinology. J Diabetes. 2013;5:406–415. https://doi.org/10.1111/1753-0407.12056.
Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd, Criqui M et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003;107:499–511. https://doi.org/10.1161/01.cir.0000052939.59093.45.
Levey AS, de Jong PE, Coresh J, El Nahas M, Astor BC, Matsushita K et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int. 2011;80:17–28. https://doi.org/10.1038/ki.2010.483.
Ye Q, Zou B, Yeo YH, Li J, Huang DQ, Wu Y et al. Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020;5:739–752. https://doi.org/10.1016/s2468-1253(20)30077-7.
Zhou F, Zhou J, Wang W, Zhang XJ, Ji YX, Zhang P et al. Unexpected Rapid Increase in the Burden of NAFLD in China From 2008 to 2018: A Systematic Review and Meta-Analysis. Hepatology. 2019;70:1119–1133. https://doi.org/10.1002/hep.30702.
Ballestri S, Nascimbeni F, Romagnoli D, Lonardo A. The independent predictors of non-alcoholic steatohepatitis and its individual histological features.: Insulin resistance, serum uric acid, metabolic syndrome, alanine aminotransferase and serum total cholesterol are a clue to pathogenesis and candidate targets for treatment. Hepatol Res. 2016;46:1074–87.https://doi.org/10.1111/hepr.12656.
Lee YJ, Lee HR, Lee JH, Shin YH, Shim JY. Association between serum uric acid and non-alcoholic fatty liver disease in Korean adults. Clin Chem Lab Med. 2010;48:175–180. https://doi.org/10.1515/cclm.2010.037.
Article CAS PubMed Google Scholar
Sirota JC, McFann K, Targher G, Johnson RJ, Chonchol M, Jalal DI. Elevated serum uric acid levels are associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in the United States: Liver ultrasound data from the National Health and Nutrition Examination Survey. Metabolism. 2013;62:392–399. https://doi.org/10.1016/j.metabol.2012.08.013.
Article CAS PubMed Google Scholar
Wei F, Li J, Chen C, Zhang K, Cao L, Wang X et al. Higher Serum Uric Acid Level Predicts Non-alcoholic Fatty Liver Disease: A 4-Year Prospective Cohort Study. Front Endocrinol (Lausanne). 2020;11:179. https://doi.org/10.3389/fendo.2020.00179.
Article PubMed PubMed Central Google Scholar
Della Torre S. Beyond the X Factor: Relevance of Sex Hormones in NAFLD Pathophysiology. Cells. 2021;10. https://doi.org/10.3390/cells10092502.
Della Torre S. Non-alcoholic Fatty Liver Disease as a Canonical Example of Metabolic Inflammatory-Based Liver Disease Showing a Sex-Specific Prevalence: Relevance of Estrogen Signaling. Front Endocrinol (Lausanne). 2020;11:572490. https://doi.org/10.3389/fendo.2020.572490.
Mumford SL, Dasharathy SS, Pollack AZ, Perkins NJ, Mattison DR, Cole SR et al. Serum uric acid in relation to endogenous reproductive hormones during the menstrual cycle: findings from the BioCycle study. Hum Reprod. 2013;28:1853–1862. https://doi.org/10.1093/humrep/det085.
Article CAS PubMed PubMed Central Google Scholar
Liu Z, Zhang Y, Graham S, Wang X, Cai D, Huang M et al. Causal relationships between NAFLD, T2D and obesity have implications for disease subphenotyping. J Hepatol. 2020;73:263–276. https://doi.org/10.1016/j.jhep.2020.03.006.
Article CAS PubMed PubMed Central Google Scholar
Kim EY, Lee HW, Lee JW, Kwon YJ, Son NH. Trends in serum uric acid levels among Korean children and adolescents between 2016 and 2020: a nationwide study. Eur J Pediatr. 2023;182:2253–2261. https://doi.org/10.1007/s00431-023-04904-6.
Article CAS PubMed PubMed Central Google Scholar
Ali N, Miah R, Hasan M, Barman Z, Mou AD, Hafsa JM et al. Association between serum uric acid and metabolic syndrome: a cross-sectional study in Bangladeshi adults. Sci Rep. 2020;10:7841. https://doi.org/10.1038/s41598-020-64884-7.
Article CAS PubMed PubMed Central Google Scholar
Ruggiero C, Cherubini A, Ble A, Bos AJ, Maggio M, Dixit VD et al. Uric acid and inflammatory markers. Eur Heart J. 2006;27:1174–1181. https://doi.org/10.1093/eurheartj/ehi879.
Comments (0)